Spravato (esketamine) is a breakthrough therapy for treatment-resistant depression, and naturally, cost and insurance coverage are top questions. The answer: yes, many insurance plans cover Spravato—but coverage varies significantly by plan, diagnosis, and whether you've already tried other treatments.
What Is Spravato?
Spravato is a nasal spray form of esketamine, a medication derived from ketamine. The FDA approved it in 2019 for rapid-acting relief of depression symptoms, especially in people who haven't responded to multiple antidepressants. Unlike oral medications that take weeks to work, Spravato can produce noticeable improvement within hours or days.
Insurance Coverage: The Basics
Most major insurance plans—including Medicaid in many states, Medicare, and private health plans—cover Spravato, but they typically require prior authorization. This means your psychiatrist must submit clinical documentation proving that you meet medical necessity criteria before treatment can begin.
The coverage decision often depends on:
- Whether you have treatment-resistant depression (typically defined as failure of at least two antidepressant trials)
- Your current psychiatric symptoms and severity
- Your specific insurance plan's formulary
- Whether your plan requires a psychiatric evaluation first
- Whether your psychiatrist has in-network status with your insurer
The Prior Authorization Process
When we recommend Spravato at Next Step Psychiatry, our clinical staff handles the prior authorization process. We submit your psychiatric evaluation, treatment history, and current symptoms to your insurance company. They review the information and decide whether to approve coverage.
This process typically takes 3-7 business days, though urgent cases can be expedited. If your insurer denies coverage, we can appeal and provide additional clinical documentation. Some patients are approved on first submission; others require a peer-to-peer conversation between our psychiatrist and your insurance company's medical director.
Out-of-Pocket Costs
If insurance covers Spravato, your out-of-pocket cost depends on your plan's coinsurance, copayment structure, and whether you've met your deductible. Each Spravato administration visit typically falls under your behavioral health or medical benefits. Some patients pay $20-50 per visit; others pay a percentage of the cost. A few plans cover it fully.
If insurance denies coverage or you're uninsured, the manufacturer (Janssen) offers patient assistance programs that can reduce out-of-pocket costs significantly. We can help you explore these programs.
Medicare & Medicaid Coverage
Medicare Part B covers Spravato when administered in a clinical setting as a physician-administered service. You'll typically pay your coinsurance (20% of the Medicare-approved amount). Medicaid coverage varies by state; most cover Spravato for patients with treatment-resistant depression, but prior authorization is required.
Frequently Asked Questions
What if my insurance denies Spravato coverage?
Don't accept denial as final. We can appeal with additional clinical information, request a peer-to-peer review, or explore alternative treatments. Some denials are reversed on appeal. Additionally, manufacturer assistance programs may make Spravato affordable without insurance coverage.
How long does prior authorization take?
Typically 3-7 business days. Urgent cases can be fast-tracked to 24 hours. We work with your insurer to expedite the process and keep you informed of the status.
Does Medicaid in Georgia cover Spravato?
Yes, Georgia Medicaid covers Spravato for eligible patients with treatment-resistant depression, but prior authorization is required. Our office can verify your coverage and eligibility.
When to See a Psychiatrist
If you've tried multiple antidepressants without adequate relief, or if you're experiencing severe, persistent depression that's affecting your ability to function, an evaluation for Spravato might be appropriate. Only a qualified psychiatrist can determine if you meet medical necessity criteria and if Spravato is right for you.
Talk to Next Step Psychiatry
At Next Step Psychiatry in Lilburn, GA, Dr. Aneel Ursani and Fathima Chowdhury, PA-C specialize in evaluating patients for Spravato and other advanced treatments for treatment-resistant depression. We manage the entire insurance process—from prior authorization to treatment monitoring—so you can focus on recovery.
4145 Lawrenceville Hwy STE 100, Lilburn, GA 30047 • 678-437-1659 • Schedule an appointment
This article is for educational purposes only and is not a substitute for individual medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.